CVS entered this industry relatively late, and has plenty of room to grow. MinuteClinic has only 1.5% market share, well below the 21% of the market that CVS’s pharmacy and specialty operations each account for. The company plans to add another 600 such clinics by 2017.
CVS’s specialty department handles the high-end, complex, life-sustaining and prohibitively expensive drugs that operate on low volume but gigantic prices. The drugs that are distributed in in this sector is rare which makes them expensive for the consumer, but lucrative for CVS. Due to the fact that the drugs are so rare, costly, and specialized, they necessitate a CVS department. The specialty revenues were $21 billion in 2013 in 2015; CVS Health’s pro forma specialty pharmacy dispensing revenues grew by more than 40%, to an estimated $29.6 billion. Its market share also increased to 30%, from 26% in